Ropes & Gray Advises Moffitt Cancer Center and OncoBay Clinical in an Investment in OncoBay by Clinscience
Ropes & Gray advised Moffitt Cancer Center and OncoBay Clinical, one of its for-profit subsidiaries, in an investment in OncoBay by Clinscience, a global clinical research organization based in Warsaw, Poland. The investment will give Clinscience’s parent company NEUCA Group a majority equity stake in OncoBay.
OncoBay is a boutique clinical research organization specializing in immuno-oncology and cell therapy, offering full-service custom curated CRO solutions for global pharmaceutical and biotech companies. The companies will work together to advance immune-oncology research for a global portfolio of clients. The transaction was announced on January 9. Financial terms were not disclosed.
The Ropes & Gray team was led by venture capital & emerging companies partner Brad Flint and tax partner Scott Pinarchick and included IP transactions partner David McIntosh, employment & benefits partners Renata Ferrari and Jenny Rikoski, tax partner Kendi Ozmon, tax counsel Gil Ghatan and employment & benefits principal Bruce Gaffney.